FindTrial
Sign In

Establishing a precise intraocular fluid detection platform for chronic fundus diseases that threaten vision

Establishing a precise intraocular fluid detection platform for chronic fundus diseases that threaten vision

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500106190
Enrollment
Unknown
Registered
2025-07-18
Start date
2023-08-11
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic retinal disease

Interventions

Control group:None
Diabetic retinopathy macular edema group:None
Wet age-related macular degeneration group:None
Venous occlusive macular edema group:None
Uveitis group:None

Sponsors

Sichuan University, West China Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with a definite diagnosis of fundus disease (including wet age-related macular degeneration wAMD, diabetic macular edema DME, retinal vein occlusive macular edema CME, uveitis macular edema); Control group: Elderly cataract patients who do not have other systemic diseases and require surgical treatment.

Exclusion criteria

Exclusion criteria: Those who refused intraocular fluid cytokine testing.

Design outcomes

Primary

MeasureTime frame
Cytokine concentration;Visual Acuity;—

Secondary

MeasureTime frame
OCT biomarker;—

Countries

China

Contacts

Public ContactLu Fang

Sichuan University, West China Hospital

Lufang@wchscu.cn+86 189 8060 2062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026